Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.
about
IRIZIO: a novel gene cooperating with PAX3-FOXO1 in alveolar rhabdomyosarcoma (ARMS)Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressorPAX7 expression in embryonal rhabdomyosarcoma suggests an origin in muscle satellite cellsShrinkage control: regulation of insulin-mediated growth by FOXO transcription factorsp21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue SarcomasInducible short-term and stable long-term cell culture systems reveal that the PAX3-FKHR fusion oncoprotein regulates CXCR4, PAX3, and PAX7 expressionGlobal gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomasDivergent functions of murine Pax3 and Pax7 in limb muscle developmentAnalysis of molecular cytogenetic alteration in rhabdomyosarcoma by array comparative genomic hybridizationForkhead box F1 is essential for migration of mesenchymal cells and directly induces integrin-beta3 expressionRegulatory landscape fusion in rhabdomyosarcoma through interactions between the PAX3 promoter and FOXO1 regulatory elementsSplice variants of the forkhead box protein AFX exhibit dominant negative activity and inhibit AFXalpha-mediated tumor cell apoptosis.Myogenin, AP2β, NOS-1, and HMGA2 are surrogate markers of fusion status in rhabdomyosarcoma: a report from the soft tissue sarcoma committee of the children's oncology group.FOXOs, cancer and regulation of apoptosisDrosophila as a model for context-dependent tumorigenesis.Current state of pediatric sarcoma biology and opportunities for future discovery: A report from the sarcoma translational research workshop.The transcriptional activator PAX3-FKHR rescues the defects of Pax3 mutant mice but induces a myogenic gain-of-function phenotype with ligand-independent activation of Met signaling in vivo.Genome-wide identification of PAX3-FKHR binding sites in rhabdomyosarcoma reveals candidate target genes important for development and cancer.Animal models of soft-tissue sarcoma.Characterization of zebrafish Pax1b and Pax9 in fin bud developmentFOXO1-FGFR1 fusion and amplification in a solid variant of alveolar rhabdomyosarcoma.Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005Inhibition of Pax2 Transcription Activation with a Small Molecule that Targets the DNA Binding Domain.Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis.Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family membersA Drosophila model of the rhabdomyosarcoma initiator PAX7-FKHR.Novel genes implicated in embryonal, alveolar, and pleomorphic rhabdomyosarcoma: a cytogenetic and molecular analysis of primary tumorsThe human T-cell leukemia virus type 1 oncoprotein tax controls forkhead box O4 activity through degradation by the proteasomeUpdate on childhood rhabdomyosarcoma.Insulin and LiCl synergistically rescue myogenic differentiation of FoxO1 over-expressed myoblastsDecisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty.Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas.Molecular genetics of pediatric soft tissue tumors: clinical application.The PAX3-FOXO1 fusion protein present in rhabdomyosarcoma interferes with normal FOXO activity and the TGF-β pathway.Family history of cancer and childhood rhabdomyosarcoma: a report from the Children's Oncology Group and the Utah Population Database.New Treatments for Rhabdomyosarcoma: the Importance of Target PracticeGenomic imbalances in pediatric intracranial ependymomas define clinically relevant groups.Examination of gene fusion status in archival samples of alveolar rhabdomyosarcoma entered on the Intergroup Rhabdomyosarcoma Study-III trial: a report from the Children's Oncology Group.Inhibiting phosphorylation of the oncogenic PAX3-FOXO1 reduces alveolar rhabdomyosarcoma phenotypes identifying novel therapy options
P2860
Q24319144-39F3A4CE-E993-4350-A16C-B1C7828FEE90Q24624817-AD77C0CC-5499-4CF8-97CC-91E312BC1311Q24651250-39CA5CA4-CF87-462A-B850-CAB1A61FD856Q24794805-50276491-8E37-4013-873E-42054FA61068Q25257047-99105439-2334-4BA0-9450-42E168D1F334Q26782842-8C4804B2-F631-40C5-B498-630A861A41C3Q28265800-54CBF889-EDCA-4A18-BD0F-D15ACCB8BD09Q28300128-38D3F577-92E6-4529-ACD9-24E92369FE20Q28505611-0BF05D10-C25C-4156-A078-ED7186394C1DQ28537996-3C369324-EAA8-41A4-8CFC-6B02E2368D9DQ28587296-352203E1-36D0-45E1-9CAC-D95AF96AD64BQ30855713-56842336-1D27-4D8F-9654-3DD8F3A329BDQ33354059-EAB44F1F-77BD-448F-9F18-05230BB7125CQ33567593-D47ABCBD-BBDD-4047-85AD-66F264018D25Q33642512-22154955-9CE4-4166-88C9-E1EC8D46E600Q33666519-5942B155-C49C-4200-AE03-B8263AC72B30Q33872384-ADA2786B-4BFD-442E-AD58-76E36A5F1AEEQ33938529-A0F910C7-0C15-403A-AF6C-9D90983E835AQ34069048-C5AE2A98-A00F-48F4-8EB8-21354796936FQ34098113-5A707A24-48FF-420B-B1E9-03A8EFECFE9CQ34101112-14D9827D-5BC1-4041-BE1B-A4E35150C4A7Q34191937-16F33171-60D6-4E5A-A220-DBD0ECC9E982Q34192795-108FA7F1-A6F3-455B-8A12-ACA0FB61BF1CQ34549454-D9877088-A40D-4349-8953-E9C954229C97Q34652138-21CF512D-2353-4D3B-8659-C16CE2FDFAB3Q34894993-6D7F50F2-A288-48D9-89C8-F322194C608CQ35037288-4F777C9E-C9D7-45EB-8AFC-FC581D5E1A04Q35070067-0A1A19DD-9FEB-4142-B3BF-E44BDC6AC1B6Q35077555-7CB43DBC-BB55-44C1-B1D7-F5E9BDF77827Q35090205-2A447CC2-D0EC-41CB-8371-18C81D3E7378Q35097402-10C5D1CE-701A-4B00-AAD0-69C68377698FQ35139549-B10279B6-28E7-49F3-97F1-EE2D3AF49E10Q35144171-2125E83B-E189-47C6-BA6A-E0F6C61E9CEDQ35183100-50830D8A-7EB6-4CC6-9502-F37520090809Q35586103-697166D9-AFF9-4656-B09C-061C26A924D9Q35602170-10F02C95-DC8B-4862-9A16-B305380BC8E5Q35729362-BF4ED06C-3BA3-4EDA-9151-18E55AD078E9Q35748208-1D1834FE-380C-4C4D-A1BC-EB179F3932D8Q35790146-9DD99DD5-2B10-40D9-A6E3-E683D489C79EQ35818209-71E96D8F-E149-4AF7-B789-721399B78CC8
P2860
Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.
@ast
Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.
@en
Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.
@nl
type
label
Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.
@ast
Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.
@en
Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.
@nl
prefLabel
Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.
@ast
Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.
@en
Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.
@nl
P2860
P356
P1433
P1476
Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.ONC.1204599
P407
P577
2001-09-01T00:00:00Z
P6179
1005002189